[1]
Rizwan, W. et al. 2022. Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan. Annals of King Edward Medical University. 27, 4 (Jan. 2022), 516–523. DOI:https://doi.org/10.21649/akemu.v27i4.4884.